Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease

NCT01536418 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01536418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01536418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
November 11, 2011
Completion date
October 17, 2013
Enrollment
255 (actual)
Sites
227

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease